His research group studied TRH (79), luteinising hormone-releasing hormone (LHRH), GHRH, bombesin/gastrin-releasing peptide (80) and somatostatin (80, 81) as well as developing LHRH analogues for the treatment of prostate cancer (82, 83). Here, GNRH1 is linked to prostate carcinoma.